Dr. Savasan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Childrens Hospital Mi Hematology/Oncology
3901 Beaubien 3rd Floor - Carl's Building
Detroit, MI 48201Phone+1 313-745-5516
Education & Training
- Children's Hospital of MichiganFellowship, Pediatric Hematology/Oncology, 1994 - 1998
- Hacettepe University FOMClass of 1984
Certifications & Licensure
- MI State Medical License 1994 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease Start of enrollment: 2007 Jan 01
- Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
- Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Rapid molluscum contagiosum resolution after maintenance chemotherapy completion.Maria S Gallardo, Sureyya Savasan
Archives of Disease in Childhood. 2023-05-01 - 1 citationsExpanding clinical spectrum of female X‐linked lymphoproliferative syndrome 2Shruthi Suryaprakash, Mohammad El-Baba, Kelly Walkovich, Süreyya Savaşan
Pediatric Blood & Cancer. 2021-02-01 - 5 citationsAn infant with severe combined immunodeficiency, osteopetrosis, chromosomally integrated herpesvirus-6 infection, and hemophagocytic syndrome: What are the links?Pragya Singh, Elizabeth Secord, Kara B. Pappas, Süreyya Savaşan
Pediatric Blood & Cancer. 2021-01-01
Press Mentions
- New Treatment for Children with Blood Disorders Comes to MichiganSeptember 25th, 2024
- Teen Boy First in Michigan to Get Gene Editing Treatment for Blood DisorderSeptember 24th, 2024
- DMC Hospital Starts New Gene Treatments for Blood DisordersSeptember 23rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: